Palmer Taylor

Title(s)Professor, Pharmacology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Ph.D.University of Wisconsin

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Optimization of nonpyridinium oximes for BChE hydrolysis of OPs in plasma
    NIH R21NS072086Sep 30, 2010 - Aug 31, 2013
    Role: Principal Investigator
    Predoctoral Research Training in Maternal and Pediatric Pharmacology
    NIH T35HD064385Apr 1, 2010 - Apr 30, 2022
    Role: Principal Investigator
    Oxime-Assisted Catalysis of Organophosphates and Reactivation of AChE
    NIH U01NS058046Sep 30, 2006 - Oct 31, 2012
    Role: Principal Investigator
    Nicotinic Receptor Template-guided Drug Design
    NIH U01DA019372Sep 30, 2004 - Jun 30, 2010
    Role: Principal Investigator
    FACILITIES CONSTRUCTION CENTERALIZED PHARMCOGENOMICS
    NIH C06RR017309Sep 15, 2003 - Sep 14, 2005
    Role: Principal Investigator
    DETECTION AND MODELS OF TOXICANT EXPOSURE
    NIH P42ES010337Jul 1, 2000 - Mar 31, 2022
    Role: Co-Investigator
    NATIONAL BIOMEDICAL COMPUTATION RESOURCE
    NIH P41RR008605Apr 15, 1994 - Apr 30, 2014
    Role: Co-Investigator
    MOLECULAR PHARMACOLOGY
    NIH R13GM042914Jun 1, 1989 - May 31, 1990
    Role: Principal Investigator
    IVEM and Image Analysis Resource
    NIH P41RR004050Dec 12, 1988 - Mar 31, 2014
    Role: Co-Investigator
    GENETIC AND RECEPTOR MECHANISMS IN HYPERTENSION
    NIH P01HL035018Mar 1, 1986 - Dec 31, 2009
    Role: Co-Investigator
    RECEPTOR REGULATION OF CA IN VASCULAR SMOOTH MUSCLE
    NIH R01GM036237Feb 1, 1986 - Jan 31, 1992
    Role: Principal Investigator
    Graduate Training in Cellular and Molecular Pharmacology
    NIH T32GM007752Jul 1, 1979 - Jun 30, 2024
    Role: Principal Investigator
    PHARMACOLOGY OF MEMBRANE ASSOCIATION RECEPTORS
    NIH R01GM024337Jul 1, 1977 - Mar 31, 1995
    Role: Principal Investigator
    Kinetics of Drug Macromolecule Complex Formation
    NIH R01GM018360Jan 1, 1975 - Nov 30, 2014
    Role: Principal Investigator
    KINETICS OF DRUG MACROMOLECULE COMPLEX FORMATION
    NIH R37GM018360Jan 1, 1975 - Dec 31, 2009
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cholinergic Capsules and Academic Admonitions. Annu Rev Pharmacol Toxicol. 2021 01 06; 61:25-46. Taylor P. PMID: 33411578.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Positron emission tomography evaluation of oxime countermeasures in live rats using the tracer O-(2-[18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate [18 F]-VXS. Ann N Y Acad Sci. 2020 11; 1479(1):180-195. Hayes TR, Blecha JE, Chao CK, Huynh TL, VanBrocklin HF, Zinn KR, Taylor PW, Gerdes JM, Thompson CM. PMID: 32436233; PMCID: PMC7677195.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    3. Adhesion, Catalysis and Signaling: A Commonality of Association Followed by Distinctive Events Driving Function. Structure. 2019 07 02; 27(7):1055-1056. Taylor P. PMID: 31269459.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    4. Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure. Chem Biol Interact. 2019 Aug 01; 308:194-197. Taylor P, Yan-Jye S, Momper J, Hou W, Camacho-Hernandez GA, Radic' Z, Rosenberg Y, Kovarik Z, Sit R, Sharpless KB. PMID: 31100277.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    5. Cholinesterase confabs and cousins: approaching forty years. Chem Biol Interact. 2013 Mar 25; 203(1):10-3. Taylor P, De Jaco A, Comoletti D, Miller M, Camp S. PMID: 23085121; PMCID: PMC3618580.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    6. Defining the determinants of nicotine selectivity. Proc Natl Acad Sci U S A. 2010 Jul 27; 107(30):13195-6. Taylor P. PMID: 20643924; PMCID: PMC2922162.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    7. From Split to Sibenik: the tortuous pathway in the cholinesterase field. Chem Biol Interact. 2010 Sep 06; 187(1-3):3-9. Taylor P. PMID: 20493179; PMCID: PMC3000743.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    8. Virtual screening against alpha-cobratoxin. J Biomol Screen. 2009 Oct; 14(9):1109-18. Utsintong M, Talley TT, Taylor PW, Olson AJ, Vajragupta O. PMID: 19734437; PMCID: PMC3191909.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    9. Application of recombinant DNA methods for production of cholinesterases as organophosphate antidotes and detectors. Arh Hig Rada Toksikol. 2007 Sep; 58(3):339-45. Taylor P, Reiner E, Kovarik Z, Radic Z. PMID: 17913689.
      View in: PubMed   Mentions: 3     Fields:    
    10. Structure-guided drug design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes. Biochem Pharmacol. 2007 Oct 15; 74(8):1164-71. Taylor P, Talley TT, Radic' Z, Hansen SB, Hibbs RE, Shi J. PMID: 17826748; PMCID: PMC3341175.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    11. Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure. Toxicology. 2007 Apr 20; 233(1-3):70-8. Taylor P, Kovarik Z, Reiner E, Radic Z. PMID: 17196318; PMCID: PMC3279330.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    12. Contemporary paradigms for cholinergic ligand design guided by biological structure. Bioorg Med Chem Lett. 2004 Apr 19; 14(8):1875-7. Taylor P, Hansen SB, Talley TT, Hibbs RE, Radic Z. PMID: 15050619; PMCID: PMC3191913.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Palmer's Networks
    Concepts (69)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California